Convergence of Market Trends in Brain Health Diagnostics

Discussion on the FDA approval of a new drug for early Alzheimer's, CMS decision to cover expensive drug, implementation of screening process, role of AI in cognitive screening, upcoming drug approval, and release of new device with improved functionality.